
Brainstorm Cell Therapeutics Granted Compliance Extension From Nasdaq
(MENAFN- PR Newswire) NEW YORK, March 26, 2025 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI ), a leading biotechnology company committed to the development and commercialization of best-in-class autologous cellular therapies for …